Vorinostat Recruiting Phase 1 Trials for GBM / Glioblastomas / Neoplasms, Brain Treatment

IndicationsStatusPurposePhase
RecruitingTreatment1
clinicaltrials.gov IdentifierTitleDrugs
NCT03426891Pembrolizumab and Vorinostat Combined With Temozolomide for Newly Diagnosed Glioblastoma